ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026
Geneva, Switzerland, November 20, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage
Geneva, Switzerland, November 20, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage